Check out this infographic from the AHNS Cutaneous Section:
Long-term follow up of the Pilot Phase II Trial of Neoadjuvant Cemiplimab in Resectable Cutaneous Squamous Cell Carcinoma was recently published.
What does this mean for our patients and the future of their care?
#AHNSSkin @DrNeilGross
Discover more from American Head & Neck Society
Subscribe to get the latest posts sent to your email.
